Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiovascular Risk Factors
Effect of estrogens on fibrinolytic factors may reduce CV disease risk
January 5th, 2006
The effect of endogenous estrogens on fibrinolytic factors may reduce cardiovascular disease risk. According to researchers from the United States, "It has been speculated that gender differences in cardiovascular disease (CVD) mortality can be attributed to the effects of estrogens on inflammation and hemostatic marker profiles. Therefore, we evaluated endogenous hormone concentrations, menopause transition stages, and adoption of exogenous hormone use in relation to hemostatic and inflammation marker concentrations in women." M.R. Sowers and colleagues wrote, "Longitudinally, we studied 3,302 participants from the Study of Women's Health Across the...
Source: Women's Health Weekly (2006-01-05)
|
